R. Q. Le

发表

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

R. Pazdur, A. Farrell, L. Nie, 2018, The oncologist.

Cancer Immunotherapy Principles and Practice

Ke Liu, Pedro Romero, Patricia A. Young, 2018 .

Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation

K. Rezvani, P. Muranski, K. Keyvanfar, 2014, Bone marrow transplantation.

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

P. Muranski, K. Keyvanfar, C. Hourigan, 2015, Bone Marrow Transplantation.

Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

A. Barrett, M. Bevans, S. Mitchell, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comorbidity Measures In Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

A. Barrett, M. Battiwalla, X. Tian, 2013 .

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

C. Hourigan, A. Barrett, S. Shanbhag, 2014, Experimental hematology.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

K. Rezvani, A. Barrett, S. Mielke, 2011, Haematologica.

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

K. Rezvani, R. Childs, S. Mielke, 2012, Cancer Immunology, Immunotherapy.

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation

C. Hourigan, A. Barrett, M. Battiwalla, 2015, Bone Marrow Transplantation.

Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell-Depleted Human Leukocyte Antigen-Matched Sibling Transplantation.

J. Barrett, M. Battiwalla, N. Dunavin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.

D. Douek, B. Hill, K. Keyvanfar, 2011, Blood.

Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors

A. Barrett, Marcus Y. Chen, R. Childs, 2020, Clinical hematology international.

CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation

M. Sabatino, C. Hourigan, A. Barrett, 2016, Supportive Care in Cancer.

Tocilizumab for Treatment of Severe or Life-Threatening Chimeric Antigen Receptor T Cell-Induced Cytokine Release Syndrome—FDA Approval Summary

A. Farrell, L. Nie, B. Habtemariam, 2018 .